Press Release Archive
Press Releases
February 2024
02.29.2024
December 2023
12.14.2023
Corporate Investments Pfizer Completes Acquisition of Seagen
12.12.2023
Corporate Financial Investments Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
March 2023
03.13.2023
Financial Investments Pfizer Invests $43 Billion to Battle Cancer
October 2022
10.05.2022
Financial Investments Pfizer Completes Acquisition of Global Blood Therapeutics
10.03.2022
Financial Finance Investments Pfizer Completes Acquisition of Biohaven Pharmaceuticals
August 2022
08.08.2022
June 2022
06.28.2022
06.23.2022
Financial Investments Vaccines Valneva and Pfizer Announce Closing of Equity Investment
06.09.2022
Financial Investments Pfizer Completes Acquisition of ReViral
06.06.2022
Financial Covid-19 Investments Vaccines Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
06.01.2022
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.